|
| 36075000 | Vancomycin With Concomitant Piperacillin/Tazobactam vs. Cefepime or Meropenem Associated Acute Kidney Injury in General Ward Patients: A Multicenter Propensity Score-Matched Study. | J Pharm Pract | 2024 |
| 35962583 | Interventions, Barriers, and Proposed Solutions Associated With the Implementation of a Protocol That Uses Clinical Decision Support and a Stress Biomarker Test to Identify ICU Patients at High-Risk for Drug Associated Acute Kidney Injury. | Ann Pharmacother | 2023 |
| 37861206 | Prevention and management of antibiotic associated acute kidney injury in critically ill patients: new insights. | Curr Opin Crit Care | 2023 |
| 37707376 | Revising the Process and Structure of the Society of Critical Care Medicine Guidelines Toward a Living Guideline Model. | Crit Care Med | 2023 |
| 37946280 | Moving toward a contemporary classification of drug-induced kidney disease. | Crit Care | 2023 |
| 37580570 | Digital health and acute kidney injury: consensus report of the 27th Acute Disease Quality Initiative workgroup. | Nat Rev Nephrol | 2023 |
| 37991760 | Use of Disease-Modifying Treatments in Patients With Sickle Cell Disease. | JAMA Netw Open | 2023 |
| 37607496 | Challenges in Pharmacovigilance: Variability in the Criteria for Determining Drug-Associated Acute Kidney Injury in Retrospective, Observational Studies. | Nephron | 2023 |
| 37644969 | Facilitators and Barriers to Interacting With Clinical Decision Support in the ICU: A Mixed-Methods Approach. | Crit Care Explor | 2023 |
| 37574018 | Qualitative analysis of healthcare provider perspectives to evaluating beta-lactam allergies. | J Hosp Infect | 2023 |
| 37316372 | A deep learning-based dynamic model for predicting acute kidney injury risk severity in postoperative patients. | Surgery | 2023 |
| 37337731 | Comparison of COVID-19 Preprint and Peer-Reviewed Versions of Studies on Therapies for Critically Ill Patients. | J Intensive Care Med | 2023 |
| 37332887 | Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study. | Ther Adv Drug Saf | 2023 |
| 37131278 | Geographic and Temporal Trends in COVID-Associated Acute Kidney Injury in the National COVID Cohort Collaborative. | Clin J Am Soc Nephrol | 2023 |
| 37223847 | Expert Consensus on the Nephrotoxic Potential of 195 Medications in the Non-intensive Care Setting: A Modified Delphi Method. | Drug Saf | 2023 |
| 36933632 | Developing a Knowledge Graph for Pharmacokinetic Natural Product-Drug Interactions. | J Biomed Inform | 2023 |
| 36823168 | Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup. | Nat Rev Nephrol | 2023 |
| 36861661 | An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System from January 2004 through September 2021. | Clin Transl Sci | 2023 |
| 34768175 | Vancomycin with concomitant piperacillin/tazobactam vs. cefepime or meropenem associated acute kidney injury in the critically ill: A multicenter propensity score-matched study. | J Crit Care | 2022 |
| 35381057 | Pandemic stimulates a variety of telepharmacy applications: Considerations for implementation, sustainability, and future directions. | Am J Health Syst Pharm | 2022 |
| 35831683 | Kidney Damage and Stress Biomarkers for Early Identification of Drug-Induced Kidney Injury: A Systematic Review. | Drug Saf | 2022 |
| 35726977 | Society of Critical Care Medicine Presidential Address-51st Annual Congress, April 2022. | Crit Care Med | 2022 |
| 35818288 | Falls prediction using the nursing home minimum dataset. | J Am Med Inform Assoc | 2022 |
| 35389144 | Consensus Obtained for the Nephrotoxic Potential of 167 Drugs in Adult Critically Ill Patients Using a Modified Delphi Method. | Drug Saf | 2022 |
| 36044050 | A ray of hope in the discord: is adding piperacillin-tazobactam to vancomycin truly more nephrotoxic? | Intensive Care Med | 2022 |
| 35991693 | Pharmacy Practice Standards for Outpatient Nephrology Settings. | Kidney Med | 2022 |
| 36093355 | COVID-19-associated AKI in hospitalized US patients: incidence, temporal trends, geographical distribution, risk factors and mortality. | medRxiv | 2022 |
| 33599896 | A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database. | Cardiovasc Drugs Ther | 2022 |
| 35000482 | Kidney and Mortality Outcomes Associated with Ondansetron in Critically Ill Patients. | J Intensive Care Med | 2022 |
| 35294951 | Nephrotoxin Exposure in the 3 Years following Hospital Discharge Predicts Development or Worsening of Chronic Kidney Disease among Acute Kidney Injury Survivors. | Am J Nephrol | 2022 |
| 32233830 | Pharmacy Personnel's Involvement in Transitions of Care of Intensive Care Unit Patients: A Systematic Review. | J Pharm Pract | 2021 |
| 35582179 | Patient-Reported Experiences after Acute Kidney Injury across Multiple Health-Related Quality-of-Life Domains. | Kidney360 | 2021 |
| 33522323 | A systematic review of cost-effectiveness analyses across the acute kidney injury landscape. | Expert Rev Pharmacoecon Outcomes Res | 2021 |
| 33731616 | Key Roles for Pharmacists in Family-Centered Care to Advance Patient Safety. | Crit Care Med | 2021 |
| 33752857 | Nephrotoxin Stewardship. | Crit Care Clin | 2021 |
| 33855858 | Development of a Theory-Informed Behavior Change Intervention to Reduce Inappropriate Prescribing of Nephrotoxins and Renally Eliminated Drugs. | Ann Pharmacother | 2021 |
| 34643577 | SCCM/ACCM Guideline and Toolkit Development Pathways. | Crit Care Med | 2021 |
| 34643576 | The Evolution of Toolkits and Bundles to Improve the Care of Sepsis Patients. | Crit Care Med | 2021 |
| 34757995 | Health system perspectives in acute kidney injury: commitment to kidney health and planning implementation interventions. | Curr Opin Crit Care | 2021 |
| 34727542 | Incidence of Serum Creatinine Monitoring and Outpatient Visit Follow-Up among Acute Kidney Injury Survivors after Discharge: A Population-Based Cohort Study. | Am J Nephrol | 2021 |
| 34389295 | Changes in Purchases for Intensive Care Medicines During the COVID-19 Pandemic: A Global Time Series Study. | Chest | 2021 |
| 34103383 | Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System Database. | Respir Care | 2021 |
| 34324872 | Feasibility of an Academic Detailing Intervention to Support Deprescribing in the Nursing Home. | J Am Med Dir Assoc | 2021 |
| 33403858 | Use of Disproportionality Analysis to Identify Previously Unknown Drug-Associated Causes of Cardiac Arrhythmias Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database. | J Cardiovasc Pharmacol Ther | 2021 |
| 32885997 | A Systemwide Approach for Navigating the Dilemma of Oral Factor Xa Inhibitor Interference With Unfractionated Heparin Anti-Factor Xa Concentrations. | Ann Pharmacother | 2021 |
| 32627672 | Dexmedetomidine for Facilitating Mechanical Ventilation Extubation in Difficult-to-Wean ICU Patients: Systematic Review and Meta-Analysis of Clinical Trials. | J Intensive Care Med | 2021 |
| 32844730 | Sedation, Analgesia, and Paralysis in COVID-19 Patients in the Setting of Drug Shortages. | J Intensive Care Med | 2021 |
| 32555051 | Benefits of Patient/Caregiver Engagement in Adverse Drug Reaction Reporting Compared With Other Sources of Reporting in the Inpatient Setting: A Systematic Review. | J Patient Saf | 2021 |
| 30309280 | Pharmacologic Management of Delirium in the ICU: A Review of the Literature. | J Intensive Care Med | 2020 |
| 32086072 | Use of tissue inhibitor of metalloproteinase 2 and insulin-like growth factor binding protein 7 [TIMP2]â¿¢[IGFBP7] as an AKI risk screening tool to manage patients in the real-world setting. | J Crit Care | 2020 |